SS

Sangam Singh

Active Director Director DIN 09363181
DIN 09363181 First appointment Oct 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2021
Shareholding value •••• Premium profile

About Sangam Singh

Data last updated:

Sangam Singh is a Director at Pinnace Pharmaceuticals Private Limited (since 2021). The company operates in Chemicals. Pinnace Pharmaceuticals Private Limited reported revenue of ₹71,701 (FY 2022).

DIN 09363181
Primary Designation Director
Industry Chemicals
First Appointment 18 Oct 2021
Oldest Company Age 5 yrs
Largest company Pinnace Pharmaceuticals Private Limited · ₹71,701 (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Oct 20212021₹71,701 (FY 2022)Active

Board colleagues of Sangam Singh

Directorship timeline

Open interactive timeline →
Pinnace Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sangam Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sangam Singh

Sangam Singh currently holds 1 directorship: Pinnace Pharmaceuticals Private Limited (Director, since 18 Oct 2021, revenue ₹71,701 (FY 2022)).

Sangam Singh was first appointed on 18 Oct 2021 as Director at Pinnace Pharmaceuticals Private Limited.

The current boards of Sangam Singh's companies include Bindia (Pinnace Pharmaceuticals Private Limited), Rajendr Kumar Sharma (Pinnace Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available